Indian pharma index bucks broader market gains on US tariff fears

India's pharma stocks .NIPHARM down ~2%, only laggard among 13 major sub-indexes; market .NSEI, .BSESN up 2.4%

U.S. President Donald Trump says will sign executive order to cut prescription prices to the level paid by other high-income countries, an amount he put at 30% to 80% less

Vishal Manchanda, pharma analyst with Systematix Institutional Equities, expects biggest impact on innovative drugmakers like Sun and Glenmark

Sun Pharma SUN.NS slides 6%, most on pharma index

Glenmark Pharma GLEN.NS down ~2%

Pharma stocks now down 11.6% YTD vs benchmark's 4% rise